Brief: TCBP Announces Dosing Of 5 New Patients In ACHIEVE
Sept 3 (Reuters) - TC Biopharm (Holdings) PLC T0U0y.F :
* TCBP ANNOUNCES DOSING OF 5 NEW PATIENTS IN ACHIEVE
* TC BIOPHARM : REMAINS POISED TO EXECUTE ON OUR CLINICAL
TRIAL
PLANS IN 2024 & INTO 2025, INCLUDING ACHIEVE & ACHIEVE2
Source text for Eikon: ID:nPnbqh3vXa
Further company coverage: T0U0y.F
((Reuters.Brief@thomsonreuters.com;))
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange